Agmatine inhibits arginine vasopressin-stimulated urea transport in the rat inner medullary collecting duct

Kidney International

Volumn 62, Issue 6, 2002, Pages 2101-2108

  Rouch, Alexander J ^a,b   Kudo, Luúcia H ^a,b  

^a OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AVP; Cyclic AMP; IMCD; Imidazoline receptor; Urea permeability; 2 adrenoceptors

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ARGIPRESSIN; CYCLIC AMP; DRUG RECEPTOR; IMIDAZOLINE RECEPTORS; UREA; URINARY TRACT AGENT; YOHIMBINE; 2 (2 IMIDAZOLIN 2 YL)QUINOXALINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ATIPAMEZOLE; IDAZOXAN; RAUWOLSCINE;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG INTERACTION; IN VITRO STUDY; KIDNEY COLLECTING TUBULE; KIDNEY MEDULLA; METABOLISM; RAT; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT; ANIMAL TISSUE; CONTROLLED STUDY; DRUG INHIBITION; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL;

ADRENERGIC ALPHA-ANTAGONISTS; AGMATINE; ANIMALS; ARGININE VASOPRESSIN; BIOLOGICAL TRANSPORT; CYCLIC AMP; DRUG INTERACTIONS; EPINEPHRINE; KIDNEY MEDULLA; KIDNEY TUBULES, COLLECTING; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; RENAL AGENTS; SYMPATHOMIMETICS; UREA; YOHIMBINE;

EID: 0036433438     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00655.x     Document Type: Article

References (48)

1. Reis DJ, Regunathan S: Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21:187-193, 2000
2. 2O transport in inner medullary collecting subsegments. Am J Physiol 253(Renal Fluid Electrolyte Physiol 22):F823-F832, 1987
3. Star RA, Nonoguchi H, Balaban R, et al: Calcium and cyclic adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct. J Clin Invest 81:1879-1888, 1988
4. +, and urea transport in rat IMCD. Am J Physiol Renal Physiol 279:F294-F301, 2000
5. 1-imidazoline receptor: From binding site to therapeutic target in cardiovascular disease. J Hypertens 15(Suppl):S9-S23, 1997
6. 2-Adrenergic mediated inhibition of water and urea permeability in the rat inner medullary collecting duct. Am J Physiol 271(Renal Fluid Electrolyte Physiol 40):F150-F157, 1996
7. Li G, Regunathan L, Barrow CJ, et al: Agmatine: An endogenous clonidine-displacing substance in the brain. Science 263:966-969, 1994
8. Kudo LH, Hébert CA, Rouch AJ: Inhibition of water permeability in the rat collecting duct: Effect of imidazoline and alpha-2 compounds. Proc Soc Exp Biol Med 221:136-146, 1999
9. Rocha AS, Kokko JP: Permeability of medullary nephron segments to urea and water: Effect of vasopressin. Kidney Int 22:379-387, 1973
10. Rocha AS, Kudo LH: Water, urea, sodium, chloride, and potassium transport in the in vitro isolated perfused papillary collecting duct. Kidney Int 22:485-491, 1982
11. Madsen KM, Tisher CC: Structural-functional relationships along the distal nephron. Am J Physiol 250(Renal Fluid Electrolyte Physiol 19):F1-F15, 1986
12. Kolesnikov Y, Jain S, Pasternak GW: Modulation of opioid analgesia by agmatine. Eur J Pharmacol 296:17-22, 1996
13. Satriano J, Kelly CJ, Blantz RC: An emerging role for agmatine. Kidney Int 56:1252-1253, 1999
14. Galea E, Regunathan S, Eliopoulos V, et al: Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 316:247-249, 1996
15. Morrissey JJ, Klahr S: Agmatine activation of nitric oxide synthase in endothelial cells. Proc Assoc Am Physicians 109:51-57, 1996
16. Molderings GJ, Menzel S, Göthert M: Imidazoline derivatives and agmatine induce histamine release from the rat stomach. Naunyn-Schmiedeberg's Arch Pharmacol 360:711-714, 1999
17. Sener A, Lebrun P, Blachier F, et al: Stimulus-secretion coupling of arginine-induced insulin release. Biochem Pharmacol 38:327-330, 1989
18. Lortie MJ, Novotny WF, Peterson OW, et al: Agmatine, a bioactive metabolite of arginine. J Clin Invest 97:413-420, 1996
19. Lortie MJ, Ishizuka S, Schwartz D, et al: Bioactive products of arginine in sepsis: Tissue and plasma composition after LPS and iNOS blockade. Am J Physiol Cell Physiol 278:C1191-C1199, 2000
20. Penner SB, Smyth DD: Natriuresis following central and peripheral administration of agmatine in the rat. Pharmacology 53:160-169, 1996
21. Coupry I, Podevin RA, Dausse J-P, et al: Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. Biochem Biophys Res Commun 147:1055-1060, 1987
22. Ernsberger P, Feinland G, Meeley MP, et al: Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. Am J Hypertens 3:90-97, 1990
23. 3H]idazoxan label different populations of imidazoline sites on rat kidney. Eur J Pharmacol 232:79-87, 1993
24. 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol Pharmacol 35:324-330, 1989
25. Maeda Y, Terada Y, Nonoguchi H, et al: Hormone and autacoid regulation of cAMP production in rat IMCD subsegments. Am J Physiol 263(Renal Fluid Electrolyte Physiol 32):F319-F327, 1992
26. Bousquet P, Feldman J, Schwartz J: Central cardiovascular effects of alpha adrenergic drugs: Differences between catecholamines and imidazolines. J Pharmacol Exp Ther 230:232-236, 1984
27. Ernsberger P, Giuliano R, Willette RN, et al: Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther 253:408-418, 1990
28. 2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol 134:1-13, 1987
29. Atlas D, Burstein Y: Isolation and partial purification of a clonidine-displacing endogenous brain substance. Eur J Biochem 144: 287-293, 1984
30. Atlas D: Molecular and physiological properties of clonidine-displacing substance. Ann N Y Acad Sci 763:314-324, 1995
31. Head GA, Chan CKS, Godwin SJ: Central cardiovascular actions of agmatine, a putative clonidine-displacing substance, in conscious rabbits. Neurochem Int 30:37-45, 1997
32. Piletz JE, Chikkala DN, Ernsberger P: Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther 272:581-587, 1995
33. 3H]-rauwolscine in the kidney of the dog. Clin Exp Pharmacol Physiol 21:649-658, 1994
34. 2-adrenoceptors in rat cerebral cortical membranes. Eur J Pharmacol 258:67-76, 1994
35. 2 receptors. Euro J Pharmacol 304:221-229, 1996
36. 2-adrenoceptors. Br J Pharmacol 128:1215-1222, 1999
37. Molderings GJ, Hentrich F, Göthert M: Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 344:630-638, 1991
38. + and water transport in Dahl rat CCD. Am J Physiol 265(Renal Fluid Electrolyte Physiol 34): F449-F460, 1993
39. Piletz JE, Ivanov TR, Sharp JD, et al: Imidazoline receptor antisera-selected (IRAS) cDNA: Cloning and characterization. DNA Cell Biol 19:319-329, 2000
40. 2-adrenoceptor agonist-induced diuresis. Am J Physiol 255(Renal Fluid Electrolyte Physiol 24):F317-F323, 1988
41. 3H]clonidine. Eur J Pharmacol 266:25-33, 1994
42. Piletz JE, Sletten K: Nonadrenergic imidazoline binding sites on human platelets. J Pharmacol Exp Ther 267:1493-1502, 1993
43. 1-imidazoline receptors. J Auton Nerv Sys 72:147-154, 1998
44. Marples D, Knepper MA, Christensen EI, et al: Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol 269(Cell Physiol 38):C655-C664, 1995
45. Sabolic I, Katsura T, Verbabatz JM, et al: The AQP2 water channel: Effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats. J Membr Biol 143:165-177, 1995
46. Yamamoto T, Sasaki S, Fushimi K, et al: Vasopressin increases AQP-CD water channel in apical membrane of collecting duct cells in Brattleboro rats. Am J Physiol 268(Cell Physiol 37):C1546-C1551, 1995
47. Inoue T, Terris J, Ecelbarger CA, et al: Vasopressin regulates apical targeting of aquaporin-2 but not UT1 urea transporter in renal collecting duct. Am J Physiol Renal Physiol 276:F559-F566, 1999
48. Nielsen S, Knepper MA: Vasopressin activates collecting duct urea transporters and water channels by distinct processes. Am J Physiol 265(Renal Fluid Electrolyte Physiol 34):F204-F213, 1993